The Role of In Vitro Detection of Drug-Specific Mediator-Releasing Cells to Diagnose Different Phenotypes of Severe Cutaneous Adverse Reactions

PROPOSE: The purpose of this study was to investigate panels of enzyme-linked immunospot assays (ELISpot) to detect drug-specific mediator releasing cells for confirming culprit drugs in severe cutaneous adverse reactions (SCARs). METHODS: Frequencies of drug-induced interleukin-22 (IL-22)-, interfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaewsongkram, Jettanong, Buranapraditkun, Supranee, Thantiworasit, Pattarawat, Rerknimitr, Pawinee, Tuchinda, Papapit, Chularojanamontri, Leena, Rerkpattanapipat, Ticha, Chanprapaph, Kumutnart, Disphanurat, Wareeporn, Chakkavittumrong, Panlop, Tovanabutra, Napatra, Srisuttiyakorn, Chutika, Srinoulprasert, Yuttana, Sukasem, Chonlaphat, Chongpison, Yuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569031/
https://www.ncbi.nlm.nih.gov/pubmed/34734507
http://dx.doi.org/10.4168/aair.2021.13.6.896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569031/
https://www.ncbi.nlm.nih.gov/pubmed/34734507
http://dx.doi.org/10.4168/aair.2021.13.6.896

Ejemplares similares